Form 4: Globus Medical Inc. COO Keith W. Pfeil Acquires 60,000 Stock Options

COO of Globus Medical, Keith W. Pfeil, reports acquisition of 60,000 stock options exercisable for Class A Common Stock.

Summary

• Keith W. Pfeil, the COO and CFO of Globus Medical Inc. (GMED), filed a Form 4 on March 28, 2025, reporting a transaction.
• On January 23, 2025, Pfeil acquired 60,000 stock options, each representing the right to buy Class A Common Stock at an exercise price of $92.42.
• These options vest over a four-year period, with one-fourth vesting on January 1, 2026, and the remainder vesting monthly over the subsequent 36 months.
• Following this transaction, Pfeil directly owns 60,000 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard executive compensation transaction. The acquisition of stock options can be seen as a positive sign of management's confidence, but it's a routine event.

Positives

• The acquisition of stock options by a high-ranking officer may indicate confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It provides transparency into the alignment of management's interests with those of shareholders.

Stakeholder Impact

• The granting of stock options aligns the executive's interests with those of the shareholders, potentially incentivizing performance that benefits the company's value.

Key Dates

Keywords

Stock Options, Form 4, Globus Medical, GMED, Keith W. Pfeil, COO, CFO, Beneficial Ownership, Securities